Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001641172-25-002783
Filing Date
2025-04-04
Accepted
2025-04-04 17:29:08
Documents
13

Document Format Files

Seq Description Document Type Size
1 forms-1.htm S-1 570350
2 ex1-1.htm EX-1.1 81996
3 ex4-8.htm EX-4.8 106999
4 ex4-9.htm EX-4.9 112598
5 ex5-1.htm EX-5.1 15490
6 ex10-30.htm EX-10.30 246085
7 ex23-1.htm EX-23.1 4020
8 ex107.htm EX-FILING FEES 40773
9 form_001.jpg GRAPHIC 33194
10 ex5-1_001.jpg GRAPHIC 43128
11 ex5-1_002.jpg GRAPHIC 37577
12 ex5-1_003.jpg GRAPHIC 16864
13 ex5-1_004.jpg GRAPHIC 860
  Complete submission text file 0001641172-25-002783.txt   1361453
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-286403 | Film No.: 25815876
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)